BSEBoard Meeting5 Aug 2026 · 5 Aug 2026, 06:11 pm
Parnax Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Standalone and Consolidated Un-audited ....
Parnax Lab Ltd · 506128
✦ AI SummaryResults
Parnax Lab Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 14/08/2026 to consider and approve Standalone and Consolidated Un-audited IND-AS Compliant Financial Results along with Limited Review Report for the quarter (Q1) and Year ended 30th June, 2026.
Analysis Scores
Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Parnax Lab Ltd - 506128 - Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Un-Audited IND- AS Compliant Financial Results Along With Limited Review Report For The Quarter (Q1) And Year Ended 30Th June, 2026.
Attachments (1)
📄pdf
Download →
fd0bbf5a-e77f-4431-bd23-4e978f0c151b.pdf
View document text
TEL. : 022 - 6825 2525 p b
FAX : 022 - 2405 7708 a 5‘ L Lt
E-Mail : inffo@naxpariab.com ar‘fl a &
Visit us at : www.naxparlab.com (Formerly Known as Krishna Deep Trade & Investment Ltd.)
CIN No. : L36912MH1982PLC027925 114, BLDG, NO. 8, JOGANI IND. COMPLEX,
SION-CHUNABHATTI, MUMBAI - 400 022, INDIA
Date: 05t August, 2026
The Department of Corporate Service
Bombay Stock Exchange Limited
Phiroze Jeejeebhoy Towers,
Dalal Street, Fort,
Mumbai - 400 001
Scrip Code: 506128
Sub.: Notice of rd Meeting pursuant to regulation 29 (1) (a) of Listing Obligation and
Disclosure Requirements, 2015
Dear Sir,
Pursuant to Regulation 29 of Listing Obligation and Disclosure Requirements, 2015, We hereby
inform you that a meeting of the Board of Directors of the Company PARNAX LAB LIMITED is
schedule to be held on Friday, August 14, 2026, at the registered office of the Company,
inter alia, to transact the following business:
1. To consider and approve Standalone and Consolidated Un-audited IND- AS Compliant
Financial Results along with Limited Review Report for the quarter (Q1) and Year ended 30%
June, 2026, pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement,
2015.
2. Any other business with the permission of the Chair.
Kindly note that the approved results will be sent to you after the conclusion of the Board meeting.
Further in compliance with the Securities and Exchange Board of India (Prohibition of Insider
Trading) Regulations 2015 and pursuant to the Company’s “Code of Conduct to Regulate, Monitor
and Report Trading in Securities of the Company”, the trading window for dealing in the equity
shares of the Company has been closed for the concerned persons, w.e.f. July 1, 2026, and the
same shall open 48 hours after the declaration of unaudited financial results.
Kindly acknowledge the receipt of the same and Oblige
Thanking You.
Yours truly,
For Parnax Lab Limited
PREET Digitally signed by
PREET VUAY
VIJAY KUKREJA
KUKREJA Vraros-oss0
Preet Kukreja
Company Secretary & Compliance Officer
(Membership No. ACS 56761)
Works : Plot No. 120, Masat Ind. Estate, Dadra & Nagar Haveli, Silvassa-396230 (India)
Plot No. 121 & 74, Masat Ind. Estate. Dadra & Nagar Haveli, Silvassa-396230 (India)